-transparent.png){kind=logo}
Salmonella typhimurium strain TM677 was mutagenized with aflatoxin B1 (AFB1) in liquid suspension culture in the presence of a rat liver postmitochondrial supernatant. Forward mutation to 8-azaguanine resistance was measured in the treated cultures and was found to increase linearly with AFB1 concentration. DNA purified from mutagenized cells was analyzed for AFB1 adduct formation by high-pressure liquid chromatography after adduct liberation. AFB1 exposures at 0.16 and 0.32 micrometer for 35 min produced 15 and 22 AFB1--DNA adducts per genome, respectively, and induced 8-azaguanine-resistant fractions of 4.9 X 10(-4) and 9.6 X 10(-4). Approximately 70% of the AFB1 bound to DNA was chromatographically identical to 2,3-dihydro-2-(N7-guanyl)-3-hydroxyaflatoxin B1 at the two AFB1 levels used.
A A Stark, and
J M Essigmann, and
A L Demain, and
T R Skopek, and
G N Wogan
July 1994,
Cancer letters,
A A Stark, and
J M Essigmann, and
A L Demain, and
T R Skopek, and
G N Wogan
May 1984,
Cancer research,
A A Stark, and
J M Essigmann, and
A L Demain, and
T R Skopek, and
G N Wogan
January 1982,
Carcinogenesis,
A A Stark, and
J M Essigmann, and
A L Demain, and
T R Skopek, and
G N Wogan
October 1984,
Carcinogenesis,
A A Stark, and
J M Essigmann, and
A L Demain, and
T R Skopek, and
G N Wogan
November 1987,
Carcinogenesis,
A A Stark, and
J M Essigmann, and
A L Demain, and
T R Skopek, and
G N Wogan
July 2014,
Carcinogenesis,
A A Stark, and
J M Essigmann, and
A L Demain, and
T R Skopek, and
G N Wogan
May 1989,
Mutagenesis,
A A Stark, and
J M Essigmann, and
A L Demain, and
T R Skopek, and
G N Wogan
December 2008,
Mutation research,
A A Stark, and
J M Essigmann, and
A L Demain, and
T R Skopek, and
G N Wogan
June 1992,
Carcinogenesis,
A A Stark, and
J M Essigmann, and
A L Demain, and
T R Skopek, and
G N Wogan
June 1992,
Mutation research,
